Related Experiment Video
Updated: Apr 25, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Pre-placement screening for tuberculosis in healthcare workers
P Giri1, S Basu2, T Sargeant1
1Sheffield Occupational Health Service, Silverwood, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK.
A one-step interferon gamma release assay (IGRA) screening programme for new healthcare workers (HCWs) in the UK appears feasible and safe for tuberculosis (TB) detection. This approach could lead to significant cost savings for occupational health services.
Area of Science:
- Occupational Health
- Infectious Disease Epidemiology
- Public Health Policy
Background:
- Healthcare workers (HCWs) face occupational risks for tuberculosis (TB) transmission.
- Current UK national guidance lacks clarity on optimal pre-placement TB screening for new HCWs.
- The appropriateness of a single-step interferon gamma release assay (IGRA) screening programme requires evaluation.
Purpose of the Study:
- To assess the feasibility of an IGRA-only TB screening programme for new HCWs.
- To identify potential cost savings associated with an IGRA-only screening approach.
- To evaluate the safety of an IGRA-only strategy by monitoring discordant test results.
Main Methods:
- Retrospective analysis of IGRA and tuberculin skin tests (TST) over three years.
- Follow-up of HCWs with discordant IGRA-negative, TST-positive results to monitor for active TB.
- Estimation of cost savings by comparing a hypothetical IGRA-only programme to the existing two-step process.
Main Results:
- 8% (96/1258) of HCWs had positive IGRA results.
- None of the 10 individuals with markedly discordant results (IGRA negative, TST >15 mm) developed active TB.
- An IGRA-only programme could save an estimated £20,453 annually.
Conclusions:
- An IGRA-only TB screening programme for new HCWs in the UK is potentially feasible and safe.
- The study suggests substantial cost savings are achievable with an IGRA-only approach.
- Further follow-up is needed to definitively confirm the long-term safety of this screening strategy.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
